The Journal of Targeted Therapies in Cancer
December 2015
Volume: 4
Issue: 6
October 2015
Volume: 4
Issue: 5
August 2015
Volume: 4
Issue: 4
June 2015
Volume: 4
Issue: 3
April 2015
Volume: 4
Issue: 2
February 2015
Volume: 4
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
3
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5